Nucleocapsid Protein as Early Diagnostic Marker for SARS
subject: SARS-CoV, Nucleocapsid protein, Monoclonal antibody, Enzyme-Linked Immunosorbent Assay, Early diagnosis, severe acute respiratory syndrome, dispatch, China
description: Serum samples from 317 patients with patients with severe acute respiratory syndrome (SARS) were tested for the nucleocapsid (N) protein of SARS-associated coronavirus, with sensitivities of 94% and 78% for the first 5 days and 6–10 days after onset, respectively. The specificity was 99.9%. N protein can be used as an early diagnostic maker for SARS.
creator: Xiao-Yan Che, Wei Hao, Yadi Wang, Biao Di, Kai Yin, Yin-Chao Xu, Changsen Feng, Zhuo-Yue Wan, Vincent C.C. Cheng, Patrick C. Y. Woo
source: Emerging Infectious Diseases
publisher: Centers for Disease Control and Prevention
date: 2004
language: EN
identifier: DOI: 10.3201/eid1011.040516
coverage: Infectious and parasitic diseases, Medicine